These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond. Kruse JL; Lapid MI; Lennon VA; Klein CJ; Toole OO; Pittock SJ; Strand EA; Frye MA; McKeon A Psychosomatics; 2015; 56(3):227-41. PubMed ID: 25975857 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care. Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625 [TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Pearlman DM; Najjar S Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425 [TBL] [Abstract][Full Text] [Related]
7. The significance of anti-neuronal antibodies for acute psychiatric disorders: a retrospective case-controlled study. Schou MB; Sæther SG; Drange OK; Krane-Gartiser K; Reitan SK; Vaaler AE; Kondziella D BMC Neurosci; 2018 Nov; 19(1):68. PubMed ID: 30390633 [TBL] [Abstract][Full Text] [Related]
8. Anti-NMDA receptor encephalitis: a cause of acute psychosis and catatonia. Ryan SA; Costello DJ; Cassidy EM; Brown G; Harrington HJ; Markx S J Psychiatr Pract; 2013 Mar; 19(2):157-61. PubMed ID: 23507817 [TBL] [Abstract][Full Text] [Related]
9. Comparisons between Psychiatric Symptoms of Patients with Anti-NMDAR Encephalitis and New-Onset Psychiatric Patients. Wang J; Zhang B; Zhang M; Chen J; Deng H; Wang Q; Sun X Neuropsychobiology; 2017; 75(2):72-80. PubMed ID: 29065417 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Schimmel M; Bien CG; Vincent A; Schenk W; Penzien J Arch Dis Child; 2009 Apr; 94(4):314-6. PubMed ID: 19307202 [TBL] [Abstract][Full Text] [Related]
18. A prospective three-year follow-up study on the clinical significance of anti-neuronal antibodies in acute psychiatric disorders. Schou MB; Sæther SG; Drange OK; Brenner E; Crespi J; Eikenes L; Mykland MS; Pintzka C; Håberg AK; Sand T; Vaaler A; Kondziella D Sci Rep; 2019 Dec; 10(1):35. PubMed ID: 31896766 [TBL] [Abstract][Full Text] [Related]
19. Psychosis in the ED: A case of NMDA receptor antibody encephalitis. Fisher J; Ellingson C; Tolby N Am J Emerg Med; 2017 Jul; 35(7):1035.e5-1035.e6. PubMed ID: 28202296 [TBL] [Abstract][Full Text] [Related]
20. N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection. Tsutsui K; Kanbayashi T; Takaki M; Omori Y; Imai Y; Nishino S; Tanaka K; Shimizu T Neuropsychiatr Dis Treat; 2017; 13():339-345. PubMed ID: 28223808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]